A detailed history of Frank, Rimerman Advisors LLC transactions in Mckesson Corp stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 967 shares of MCK stock, worth $697,932. This represents 0.05% of its overall portfolio holdings.

Number of Shares
967
Previous 807 19.83%
Holding current value
$697,932
Previous $459,000 41.61%
% of portfolio
0.05%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$566.21 - $672.99 $90,593 - $107,678
160 Added 19.83%
967 $650,000
Q4 2024

Feb 10, 2025

BUY
$482.27 - $628.5 $8,198 - $10,684
17 Added 2.15%
807 $459,000
Q3 2024

Oct 24, 2024

SELL
$479.06 - $630.38 $52,696 - $69,341
-110 Reduced 12.22%
790 $390,000
Q2 2024

Aug 13, 2024

BUY
$518.81 - $607.81 $463,816 - $543,382
894 Added 14900.0%
900 $525,000
Q4 2023

Feb 13, 2024

BUY
$437.42 - $470.64 $2,624 - $2,823
6 New
6 $2.78 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $104B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.